Agilent Technologies, Inc. (NYSE: A) Q2 2025 Earnings Call | 5/29/2025
AI Summary
In Agilent's Q2 2025 conference call, CEO Porek McDonald and CFO Bob McMahon reported strong financial performance, with revenue of $1.67 billion, up 6% reported and 5.3% core year-over-year, exceeding expectations. EPS grew 7% to $1.31, driven by growth across all regions, particularly China (10%) and India (high-teens). The company saw robust demand in pharma (6%), diagnostics and clinical (8%), environmental and forensics (6%, led by 70%+ PFAS growth), and food (8%), though academia and government declined slightly (2%). The Ignite transformation program delivered early wins, including $130 million in projected 2025 savings, enhanced pricing, and tariff mitigation. Agilent maintained its full-year core growth guidance of 2.5–3.5% and EPS of $5.54–$5.61, absorbing $50 million in tariff costs. The company also launched innovative products like the Seahorse XF Flex Analyzer and Infinity Lab Pro IQ series, reinforcing its long-term growth strategy.
About this video
Agilent Technologies, Inc. (NYSE: A) reported strong Q2 2025 results on May 29, 2025, with revenue rising 6% year-over-year to $1.67 billion and core growth of 5.3%. Adjusted earnings per share (EPS) climbed 7% to $1.31, beating analyst estimates and reflecting effective cost management despite incremental tariff costs and ongoing currency headwinds. Gross margin was 54.1%, and operating margin stood at 25.1%, absorbing higher input costs while maintaining profitability. Segment highlights included 9% growth in the Agilent CrossLab Group (driven by consumables and automation), 3% growth in Life Sciences and Diagnostics (with strong Pathology and NASD performance), and flat core growth in the Applied Markets Group. Cash flow from operations totaled $221 million, with $165 million returned to shareholders via share repurchases and $70 million paid in dividends. Management raised full-year guidance, now projecting revenue between $6.73 billion and $6.81 billion (3.4%–4.6% growth) and EPS of $5.54–$5.61 (up to 6% growth). The company expects a $50 million gross tariff impact in the second half of 2025 but has mitigation strategies in place. Agilent remains focused on innovation, digital transformation, and operational efficiency, positioning itself well for continued growth in life sciences, diagnostics, and applied chemical markets. About Inside Ticker: For more expert analysis and real-time updates on Agilent Technologies, Inc. (NYSE: A) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports, financial insights, and the latest news on leading companies. #Agilent #A #EarningsCall #Q22025 #LifeSciences #Diagnostics #StockMarket #Investing #InsideTicker
Video Stats
More from this category
Dell Technologies Inc. (NYSE: DELL) Q1 2026 Earnings Call | AI Server Demand | 5/30/2025
Inside Ticker
Mama's Creations, Inc. (NASDAQ: MAMA) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker
Sportsman’s Warehouse Holdings, Inc. (NASDAQ: SPWH) Q1 2025 Earnings Call | 6/3/2025
Inside Ticker
Hewlett Packard Enterprise Company (NYSE: HPE) Q2 2025 Earnings Call | 6/3/2025
Inside Ticker
Yext, Inc. (NYSE: YEXT) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker
Elastic N.V. (NYSE: ESTC) Q4 2025 Earnings Call | Cloud Revenue Surges & AI Platform | 5/30/2025
Inside Ticker
CrowdStrike Holdings, Inc. (NASDAQ: CRWD) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker
Zscaler (ZS) Q3 2025 Earnings Call | Revenue Beats & AI Security Highlights | May 2025
Inside Ticker
BARK, Inc. (NYSE: BARK) Q4 2025 Earnings Call | 6/4/2025
Inside Ticker
lululemon athletica inc. (NASDAQ: LULU) Q1 2025 Earnings Call | 6/5/2025
Inside Ticker
Sprinklr, Inc. (NYSE: CXM) Q1 2026 Earnings Call | 6/4/2025
Inside Ticker
Braze, Inc. (NASDAQ: BRZE) Q1 2026 Earnings Call | 6/5/2025
Inside Ticker